RNA Seq profiling reveals a novel expression pattern of TGF-β target genes in human blood eosinophils.

[1]  F. Quintana,et al.  Immunological Relevance of the Coevolution of IDO1 and AHR , 2014, Front. Immunol..

[2]  J. Alcorn,et al.  Absence of c-Jun NH2-terminal kinase 1 protects against house dust mite-induced pulmonary remodeling but not airway hyperresponsiveness and inflammation. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[3]  Dean Sheppard,et al.  TGF-β activation and function in immunity. , 2014, Annual review of immunology.

[4]  A. von Deimling,et al.  Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR , 2014, Oncotarget.

[5]  N. Mazure,et al.  Hypoxic VDAC1: a potential mitochondrial marker for cancer therapy. , 2014, Advances in experimental medicine and biology.

[6]  R. Kordek,et al.  CD151 in cancer progression and metastasis: a complex scenario , 2014, Laboratory Investigation.

[7]  D. Shepherd,et al.  Role of the aryl hydrocarbon receptor (AhR) in lung inflammation , 2013, Seminars in Immunopathology.

[8]  D. Steinhilber,et al.  CD69 Is a TGF-β/1α,25-dihydroxyvitamin D3 Target Gene in Monocytes , 2013, PloS one.

[9]  E. Huang,et al.  Transcriptional Corepressors HIPK1 and HIPK2 Control Angiogenesis Via TGF-β–TAK1–Dependent Mechanism , 2013, PLoS biology.

[10]  Liang-Tung Yang,et al.  Differential response of epithelial stem cell populations in hair follicles to TGF-β signaling. , 2013, Developmental biology.

[11]  M. Capron,et al.  Involvement of eosinophils in the anti-tumor response , 2012, Cancer Immunology, Immunotherapy.

[12]  Eric Meggers,et al.  PIM1 kinase as a target for cancer therapy , 2012, Expert opinion on investigational drugs.

[13]  E. Meggers,et al.  PIM 1 kinase as a target for cancer therapy , 2012 .

[14]  J. Malter,et al.  Transforming Growth Factor-β1 Antagonizes Interleukin-5 Pro-Survival Signaling by Activating Calpain-1 in Primary Human Eosinophils. , 2011, Journal of clinical & cellular immunology.

[15]  A. Cesario,et al.  The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer. , 2011, Current medicinal chemistry.

[16]  Q. Hamid,et al.  Role of transforming growth factor-β in airway remodeling in asthma. , 2011, American journal of respiratory cell and molecular biology.

[17]  H. Hasegawa,et al.  Peroxisome Proliferator-Activated Receptor α and γ Agonists Together with TGF-β Convert Human CD4+CD25− T Cells into Functional Foxp3+ Regulatory T Cells , 2010, The Journal of Immunology.

[18]  Pilar Martín,et al.  The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. , 2010, The Journal of allergy and clinical immunology.

[19]  D. Umetsu,et al.  The many paths to asthma: phenotype shaped by innate and adaptive immunity , 2010, Nature Immunology.

[20]  Hao Wu,et al.  Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation. , 2010, Molecular cell.

[21]  Jodie L Simpson,et al.  ONCOSTATIN M (OSM) IS INCREASED IN ASTHMA WITH INCOMPLETELY REVERSIBLE AIRFLOW OBSTRUCTION , 2009, Experimental lung research.

[22]  I. Dozmorov,et al.  Internal standard-based analysis of microarray data. Part 1: analysis of differential gene expressions , 2009, Nucleic acids research.

[23]  Q. Sang,et al.  ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. , 2009, Current pharmaceutical design.

[24]  T. Hofmann,et al.  How cells switch HIPK2 on and off , 2009, Cell Death and Differentiation.

[25]  Robert G. Ramsay,et al.  MYB function in normal and cancer cells , 2008, Nature Reviews Cancer.

[26]  神﨑 美玲.  Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-β target gene expression , 2008 .

[27]  H. Shin,et al.  Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patients. , 2007, The Journal of allergy and clinical immunology.

[28]  R. Murphy,et al.  The regulatory role of TGF‐β in airway remodeling in asthma , 2007 .

[29]  R. Murphy,et al.  The regulatory role of TGF-beta in airway remodeling in asthma. , 2007, Immunology and cell biology.

[30]  Ravi Kiran Reddy Kalathur,et al.  Expression profiling of genes regulated by TGF-beta: Differential regulation in normal and tumour cells , 2007, BMC Genomics.

[31]  J. Egan,et al.  Microarray identifies ADAM family members as key responders to TGF-β1 in alveolar epithelial cells , 2006, Respiratory research.

[32]  D. Wildeboer,et al.  Metalloproteinase Disintegrins ADAM8 and ADAM19 Are Highly Regulated in Human Primary Brain Tumors and their Expression Levels and Activities Are Associated with Invasiveness , 2006, Journal of neuropathology and experimental neurology.

[33]  F. Berenbaum,et al.  New Target Genes for NOV/CCN3 in Chondrocytes: TGF‐β2 and Type X Collagen , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  I. Adcock,et al.  Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. , 2005, European journal of pharmacology.

[35]  A. Nicholson,et al.  Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts , 2004, Respiratory research.

[36]  Lin Ying Liu,et al.  Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. , 2004, American journal of respiratory cell and molecular biology.

[37]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  A. Musani,et al.  Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)‐β1, TGF‐β2, interleukin (IL)‐4 and IL‐13 after segmental allergen challenge and their effects on α‐smooth muscle actin and collagen III synthesis by primary human lung fibroblasts , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  I. Adcock,et al.  Allergen‐induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N‐terminal kinase , 2003, British journal of pharmacology.

[40]  Y. Shyr,et al.  Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line , 2003, Breast Cancer Research.

[41]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Verrecchia,et al.  Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach* , 2001, The Journal of Biological Chemistry.

[43]  K. Shirato,et al.  Activation and transforming growth factor-beta production in eosinophils by hyaluronan. , 2000, American journal of respiratory cell and molecular biology.

[44]  Li Liu,et al.  Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressions. , 2000, Anticancer research.

[45]  J. Mauël,et al.  CD69 and regulation of the immune function. , 1999, Immunopharmacology and immunotoxicology.

[46]  W. Luttmann,et al.  CD69 surface expression on human lung eosinophils after segmental allergen provocation. , 1999, The European respiratory journal.

[47]  M. Dalton,et al.  Differential Response of Mesoderm- and Neural Crest-Derived Smooth Muscle to TGF-β1: Regulation of c-myb and α1 (I) Procollagen Genes , 1997 .

[48]  M. Dalton,et al.  Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes. , 1997, Experimental cell research.

[49]  S. Stafford,et al.  Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis , 1994, The Journal of experimental medicine.

[50]  T. Ogawa,et al.  [CT and MRI diagnosis of hemorrhagic infarction]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.

[51]  N. Narita,et al.  [Expression of activation antigen CD69 on eosinophils]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.

[52]  P. Leder,et al.  An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. , 1992, Science.

[53]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[54]  A. Dvorak,et al.  Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. , 1988, Blood.

[55]  G. Gleich,et al.  Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. , 1984, The American review of respiratory disease.